Altamira Therapeutics (CYTO) to Release Earnings on Tuesday

Altamira Therapeutics (NASDAQ:CYTO) will post its quarterly earnings results before the market opens on Tuesday, September 24th.

Altamira Therapeutics Trading Down 5.3 %

CYTO stock traded down $0.04 during midday trading on Friday, reaching $0.71. The stock had a trading volume of 53,763 shares, compared to its average volume of 895,984. Altamira Therapeutics has a 52-week low of $0.71 and a 52-week high of $17.20. The company’s fifty day simple moving average is $1.00 and its 200 day simple moving average is $1.39.

About Altamira Therapeutics

Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland and Australia. The company develops and supplies OligoPhore/SemaPhore platforms, which are peptide-based nanoparticle technologies for ribonucleic acid delivery to extrahepatic tissues. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens.